Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120104343 | 12010434 | 3 | F | 20160705 | 20160205 | 20160714 | EXP | US-PFIZER INC-2016051626 | PFIZER | GRAY,D., FOO D.. REVERSIBLE MYOCLONUS, ASTERIXIS, AND TREMOR ASSOCIATED WITH HIGH DOSE TRIMETHOPRIM-SULFAMETHOXAZOLE: A CASE REPORT. JOURNAL OF SPINAL CORD MEDICINE. 2016;39 (1):115-117 | 66.00 | YR | M | Y | 0.00000 | 20160714 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120104343 | 12010434 | 1 | PS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | 4 CYCLES | U | UNK | 50467 | |||||||||
| 120104343 | 12010434 | 2 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | UNK | U | UNK | 71484 | |||||||||
| 120104343 | 12010434 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 4 CYCLES | U | 0 | ||||||||||
| 120104343 | 12010434 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 4 CYCLES | U | UNK | 0 | |||||||||
| 120104343 | 12010434 | 5 | SS | RITUXIMAB | RITUXIMAB | 1 | 4 CYCLES | U | UNK | 0 | |||||||||
| 120104343 | 12010434 | 6 | SS | ACICLOVIR | ACYCLOVIR | 1 | LONG TERM | U | 0 | ||||||||||
| 120104343 | 12010434 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | U | 0 | ||||||||||
| 120104343 | 12010434 | 8 | SS | ACYCLOVIR /00587301/ | ACYCLOVIR | 1 | UNK | U | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120104343 | 12010434 | 1 | B-cell lymphoma |
| 120104343 | 12010434 | 2 | B-cell lymphoma |
| 120104343 | 12010434 | 3 | B-cell lymphoma |
| 120104343 | 12010434 | 4 | B-cell lymphoma |
| 120104343 | 12010434 | 5 | B-cell lymphoma |
| 120104343 | 12010434 | 7 | B-cell lymphoma |
| 120104343 | 12010434 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120104343 | 12010434 | OT |
| 120104343 | 12010434 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120104343 | 12010434 | Immunosuppression | |
| 120104343 | 12010434 | Pneumocystis jirovecii pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120104343 | 12010434 | 1 | 20130201 | 0 | ||
| 120104343 | 12010434 | 2 | 20130201 | 0 | ||
| 120104343 | 12010434 | 3 | 201302 | 0 | ||
| 120104343 | 12010434 | 4 | 20130201 | 0 | ||
| 120104343 | 12010434 | 5 | 20130201 | 0 |